FDAnews Device Daily Bulletin

Migraine Treatment Device Wins Marketing Clearance

Sept. 13, 2017

Devicemaker eNeura received 510(k) clearance from the FDA for the eNeura Spring TMS for treatment of migraine headache.

The prescription-only device uses single-pulse transcranial magnetic stimulation to induce a mild electric current that modulates nerve cells in the brain. Patients push a button to deliver a magnetic pulse to treat a migraine attack and or to prevent the onset of future migraine attacks.

SpringTMS has CE Marking in Europe for the acute treatment of migraine and migraine prevention.

View today's stories